StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report published on Wednesday morning. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Down 2.1 %

NYSE ENZ opened at $0.52 on Wednesday. Enzo Biochem has a 52-week low of $0.41 and a 52-week high of $1.40. The company has a fifty day moving average of $0.65 and a 200-day moving average of $0.95.

Enzo Biochem (NYSE:ENZ) last issued its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share (EPS) for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC lifted its holdings in shares of Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares during the last quarter. Virtu Financial LLC purchased a new stake in Enzo Biochem during the fourth quarter valued at about $35,000. Wittenberg Investment Management Inc. boosted its position in Enzo Biochem by 60.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after buying an additional 70,400 shares during the period. BBR Partners LLC bought a new position in shares of Enzo Biochem during the third quarter valued at about $112,000. Finally, Lepercq De Neuflize Asset Management LLC bought a new position in shares of Enzo Biochem during the fourth quarter valued at about $88,000. 36.90% of the stock is currently owned by institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.